ArticleAlimentary pharmacology & therapeutics2026
Socioeconomic Inequalities in Receipt of Curative-Intent Treatment and Survival After Surveillance-Detected Hepatocellular Carcinoma: A Nationwide Cohort Study.
Article in Alimentary pharmacology & therapeutics, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Socioeconomic Inequalities in Receipt of Curative-Intent Treatment and Survival After Surveillance-Detected Hepatocellular Carcinoma: A Nationwide Cohort Study.Alimentary pharmacology & therapeutics · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
backgroundSurveillance for hepatocellular carcinoma (HCC) aims to enable early diagnosis and receipt of curative-intent treatment; however, socioeconomic status (SES) influences both participation in surveillance and subsequent outcomes. Whether SES-related disparities persist among individuals diagnosed through surveillance remains unclear.
aimsTo examine sociodemographic factors associated with receipt of curative-intent treatment and mortality among individuals with surveillance-detected HCC.
methodsWe conducted a nationwide cohort study including adults with cirrhosis and surveillance-detected HCC diagnosed in Sweden between January 1, 2012, and December 31, 2022. Sociodemographic data and outcomes were obtained through linkage to national registers. The primary outcome was receipt of curative-intent treatment, analysed using multivariable logistic regression. Post-treatment mortality was assessed using multivariable Cox regression.
resultsAmong 1,514 individuals with surveillance-detected HCC, 845 (56%) were diagnosed at an early stage, and 974 (64%) received curative-intent treatment. After adjustment for tumour characteristics, liver disease aetiology and severity, performance status, comorbidities, and calendar period, low SES was independently associated with a lower likelihood of receiving curative-intent treatment (adjusted odds ratio 0.42, 95% CI 0.26-0.66, low vs. high SES). Among those treated with curative intent, low SES was also associated with higher mortality (adjusted hazard ratio 1.50, 95% CI 1.10-2.00).
conclusionsSocioeconomic inequalities in the receipt of curative-intent treatment and survival persist even among individuals with surveillance-detected HCC within a universal healthcare system. These findings indicate that surveillance alone is insufficient to ensure equitable outcomes and underscore the need for regionally tailored, people-centred strategies that address social vulnerability across the HCC care continuum.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.